Results 231 to 240 of about 1,009,444 (403)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccines. [PDF]

Front Immunol
Bodle J, Burge D, Gounder G, Vandenberg K, Laurie K, Rockman S.   +5 more
europepmc   +1 more source

Potency Selection

International Journal of Science and Research (IJSR), 2022
openaire   +1 more source

IN VITRO ACTIVITY OF VARIOUS POTENCIES OF HOMEOPATHIC DRUG THUJA AGAINST MOLDS INVOLVED IN MYCOTIC KERATITIS

, 2014
R. Asha, Parveen Nisha, Komal Tahawar Khan, Mythili Ayyagari, Anamangadan Shafeeq Hassan, Kuppusamy Selvam, M. Palanisamy, Coimbatore Subramanian Shobana   +7 more
openalex   +1 more source

A case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency

, 2011
J Descamps, D Giffroy, É. Rémy, Frédéric Mortiaux, Jean‐Claude Mareschal, Cecile Ponsar, Michel Duchêne   +6 more
openalex   +1 more source

Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency

Clinical Gastroenterology and Hepatology, 2017
D. Graham, Aylin Tansel
semanticscholar   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Machine Learning-Based QSAR Screening of Colombian Medicinal Flora for Potential Antiviral Compounds Against Dengue Virus: An In Silico Drug Discovery Approach. [PDF]

Pharmaceuticals (Basel)
Montenegro-Herrera SA, Sosa A, Echeverri-Jiménez I, Castaño-Valencia RS, Jerez-Valderrama AM.   +4 more
europepmc   +1 more source

Identification of novel thiocarboxanilide derivatives that suppress a variety of drug-resistant mutant human immunodeficiency virus type 1 strains at a potency similar to that for wild-type virus [PDF]

, 1996
Jan Balzarini, W G Brouwer, D.C. Dao, E M Osika, Erik De Clercq   +4 more
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source